Achema middle east

Packaging & Labelling

Pfizer recalls Robitussin DM product due to labeling errors

Pfizer is voluntarily recalling its cough syrup medicine, Robitussin DM product, due to errors in its labeling, according to the US FDA . Robitussin DM product contains Dextromethorphan HBr 15mg and Guaifenessin 100mg per...

Amcor, Rychiger launch new packaging design for healthcare products

Amcor Flexibles, a provider of packaging solutions for the healthcare industry, and Rychiger are introducing Amcor MediCan for healthcare products. Amcor MediCan with aluminum container technology provides a high degree of protection to healthcare...

Catalent to sell US commercial packaging operations

Catalent Pharma Solutions has entered into a definitive agreement to sell its US commercial packaging operations based in Philadelphia, Pennsylvania, and Woodstock, Illinois, to a company affiliated with Frazier Healthcare. The transaction, which is...

AlpVision, Nolato partner to protect pharmaceutical primary plastic packaging

AlpVision and Nolato Medical have collaborated to protect primary plastic packaging and medical devices against counterfeiting. The AlpVision's patented Fingerprint technology is used in the partnership, which enables brand owners in the pharmaceutical industry...

FDA approves Sunovion Latuda label update to extend dose range

The FDA has approved the stretched dose range for Sunovion Pharmaceuticals' Latuda for the treatment of patients with schizophrenia. After the review of the supplemental new drug application (sNDA), which was submitted in June...

Almac Pharma Services expands packaging operations in US

Almac Pharma Services business unit has expanded its established commercial packaging operations with a $10m investment in a new 100,000sq ft commercial facility in Audubon, PA, US.  The company clients will now be able...

Novartis to update high blood pressure drug label

Novartis has planned to update the Rasilez's labelling to include contraindications against combined use with a number of products. The company will follow the advice of the EMA's Committee for Medicinal Products for Human Use...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »